| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $16.6M | -24.2% |
| R&D Expense | $0 | -100.0% |
| SG&A Expense | $12.4M | -21.4% |
| Operating Income | -$21.4M | +28.6% |
| Interest Expense | $1.0M | -15.5% |
| Income Tax | $150K | +1053.8% |
| Net Income | -$9.5M | +59.4% |
| EPS (Basic) | -$0.48 | +75.1% |
| EPS (Diluted) | -$0.48 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.4M | +825.8% |
| Current Assets | $17.8M | +31.7% |
| Total Assets | $43.2M | -5.3% |
| Current Liabilities | $3.9M | -27.1% |
| Stockholders' Equity | $39.3M | +48.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.6M | +30.5% |
| Capital Expenditures | $8.9M | +473.0% |
| Investing Cash Flow | $4.0M | +57.3% |
| Financing Cash Flow | $5.4M | +75.8% |
| Free Cash Flow | -$13.5M | -66.0% |
| +75.1% |